Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London · Delayed Price · Currency is GBP · Price in USD 605.14
+5.74 (0.96%)
At close: Oct 3, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 46.16 billion as of October 3, 2025. Its market cap has decreased by -50.40% in one year.
Market Cap
46.16B
Enterprise Value
35.17B
Revenue
10.37B
Ranking
n/a
PE Ratio
14.19
Stock Price
605.14
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 46.16B, an increase of 47,928.82%. That is a compound annual growth rate of 20.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 46.16B | -24.59% |
| Dec 31, 2024 | 61.22B | -16.52% |
| Dec 29, 2023 | 73.33B | 14.66% |
| Dec 30, 2022 | 63.95B | 31.15% |
| Dec 31, 2021 | 48.76B | 30.57% |
| Dec 31, 2020 | 37.35B | 20.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.16B |
| GSK plc | 65.55B |
| Haleon | 29.53B |
| Smith & Nephew | 11.62B |
| ConvaTec Group | 4.79B |
| Hikma Pharmaceuticals | 4.09B |
| HUTCHMED (China) | 2.08B |
| Genus | 1.67B |